Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Progyny (PGNY)
NASDAQ:PGNY
Progyny (PGNY) Stock Price & Analysis
524 Followers
PGNY Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$29.44 - $44.95
Previous Close$31.88
Volume1.30M
Average Volume (3M)824.28K
Market Cap
$3.08B
Enterprise Value$2.72B
Total Cash (Recent Filing)$371.09M
Total Debt (Recent Filing)$17.24M
Price to Earnings (P/E)51.7
Beta1.45
Next Earnings
May 02, 2024EPS Estimate
$0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.62
Shares Outstanding96,499,402
10 Day Avg. Volume540,790
30 Day Avg. Volume824,276
Standard Deviation0.17
R-Squared0.24
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)5.95
Price to Sales (P/S)2.90
Price to Cash Flow (P/CF)21.40
P/FCF Ratio21.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.50
Enterprise Value/Gross Profit11.40
Enterprise Value/Ebitda80.41
Forecast
1Y Price Target
$47.63Price Target Upside49.40% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
Progyny News
Bulls Say, Bears Say
Bulls Say
Employment BenefitsExpansion of fertility benefits is a growing trend among companies, enhancing employee retention and attracting new talent, with tech companies leading the charge.
Financial HealthProgyny continues to demonstrate financial strength with strong cash flow, a clean balance sheet, and a track record of retaining nearly all of its clients.
Market DemandDemand for fertility treatment remains robust, as patients prioritize family building and are willing to finance their pursuit of fertility treatments.
Bears Say
Earnings ReportPGNY's 4Q'23 earnings and 2024 guidance came in below investor expectations.
Financial GuidanceJanuary/February mix shift to lower margin IVF procedures weighed on the first quarter and full year guidance.
Revenue PerformanceA larger than expected decline in utilization resulted in slower fertility revenue growth.
---
Ownership Overview
39.29% Insiders
33.74% Mutual Funds
21.78% Other Institutional Investors
5.19% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PGNY FAQ
What was Progyny’s price range in the past 12 months?
Progyny lowest stock price was $29.44 and its highest was $44.95 in the past 12 months.
What is Progyny’s market cap?
Currently, no data Available
When is Progyny’s upcoming earnings report date?
Progyny’s upcoming earnings report date is May 02, 2024 which is in 13 days.
How were Progyny’s earnings last quarter?
Progyny released its earnings results on Feb 27, 2024. The company reported $0.13 earnings per share for the quarter, beating the consensus estimate of $0.107 by $0.023.
Is Progyny overvalued?
According to Wall Street analysts Progyny’s price is currently Undervalued.
Does Progyny pay dividends?
Progyny does not currently pay dividends.
What is Progyny’s EPS estimate?
Progyny’s EPS estimate is $0.13.
How many shares outstanding does Progyny have?
Progyny has 96,499,405 shares outstanding.
What happened to Progyny’s price movement after its last earnings report?
Progyny reported an EPS of $0.13 in its last earnings report, beating expectations of $0.107. Following the earnings report the stock price went down -15.053%.
Which hedge fund is a major shareholder of Progyny?
Among the largest hedge funds holding Progyny’s share is Crestwood Capital Management, L.P.. It holds Progyny’s shares valued at 17M.
---
Progyny Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$47.63 (49.40% Upside)
$47.63 (49.40% Upside)
Blogger Sentiment
Bullish
PGNY Sentiment 85%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 128.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 5.9%
Last 30 Days ▲ 4.3%
Last 30 Days ▲ 4.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
0.49%
12-Months-Change
Fundamentals
Return on Equity
13.34%
Trailing 12-Months
Asset Growth
39.80%
Trailing 12-Months
Company Description
Progyny
Progyny, Inc. is a medical device company, which engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools. Its services include egg freezing, IVF treatment, surrogacy, podcast, adoption, and Eeva Test. The company was founded on April 03, 2008 and is headquartered in New York, NY.
---
PGNY Earnings Call
Q4 2024
0:00 / 0:00
---
PGNY Stock 12 Months Forecast
Average Price Target
$47.63
▲(49.40% Upside)
Technical Analysis
Best Analysts Covering PGNY
1 Year
1 Year Success Rate
4/8 ratings generated profit
1 Year Average Return
+20.50%
reiterated a buy rating 5 months ago
Copying Glen Santangelo's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +20.50% per trade.
---